Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. research leads to novel vitronectin antagonists for osteoporosis, cancer, etc.

June 8, 1998

Sodium channel modulators under evaluation at Takeda

June 8, 1998

Dopamine agonists from AHP particularly useful in the treatment of schizophrenia

June 8, 1998

Lilly patents nonclassical antifolates for cancer, arthritis and psoriasis

June 8, 1998

Bronchotherapeutic agents in development at Byk Gulden

June 8, 1998

Fujisawa compounds lower blood cholesterol, triglyceride and lipid levels

June 5, 1998

Series of dopamine receptor subtype-selective ligands developed at Pfizer

June 5, 1998

Synthelabo discloses new agents for urinary incontinence

June 5, 1998

Cryptophycins for cancer, fungal infections described in patent literature

June 5, 1998

Novel series of 5-HT1F agonists under study at Lilly

June 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...